Home › Funds › Vivo Capital, LLC › VALN
Vivo Capital, LLC position in VALN
VALNEVA SE SPONSORED ADS · Health Care
Vivo Capital, LLC reported holding 763,199 shares of VALN (VALNEVA SE SPONSORED ADS) in its Q3 2026 13F filing — a position valued at US$4.7M, representing 0.54% of its reported portfolio and ranking #40 among its reported holdings. Vivo Capital, LLC has disclosed VALN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Vivo Capital, LLC's VALN position evolved
Vivo Capital, LLC first disclosed a stake in VALN in Q2 2026 at 763,199 shares (US$4.0M). The position peaked in Q3 2026 at 763,199 shares, worth US$4.7M. Across 2 filings, Vivo Capital, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 763,199 shares valued at US$4.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 763.20K | $3.99M | New |
| Q3 2026 | 763.20K | $4.72M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VALN and 13F data
VALN (VALNEVA SE SPONSORED ADS) is a Health Care company. 21 other funds we track also report a position in VALN — the largest reported positions include Frazier Life Sciences Management, L.P. (US$12.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VALN
- Frazier Life Sciences Management, L.P. 2.29M sh · $11.99M · Q2 2026
More on Vivo Capital, LLC
FAQ
How long has Vivo Capital, LLC held VALN?
Vivo Capital, LLC has disclosed VALN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Vivo Capital, LLC's current position in VALN?
As of Q3 2026, Vivo Capital, LLC holds 763.20K shares of VALN (VALNEVA SE SPONSORED ADS), valued at $4.72M, representing 0.54% of its reported portfolio and ranking #40.
Has Vivo Capital, LLC been buying or selling VALN?
In the latest 13F filing (Q3 2026), Vivo Capital, LLC held unchanged its position in VALN. The position peaked in Q3 2026 at 763.20K shares.
Which other funds hold VALN?
Other major institutional holders of VALN include Frazier Life Sciences Management, L.P., among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.